The need for diagnosis, treatment and prevention of AITD is also due to the need to prevent concomitant diseases, including disorders of the cardiovascular system, hypercholesterolemia, atrial fibrillation, encephalopathy, others autoimmune diseases ( Cellular and humoral immunity in the pathogenesis of AITD In addition to genetic, cellular and humoral immune mechanisms, loss of immune tolerance to thyroid autoantigens is the basis for the development of AITD
Propionil L-Carnitina: 1.000-4.000 mg al da
Y., Mahadir Naidu, B., Ling Miaw Yn, J., Rodzlan Hasani, W
GLP-1 safety: While FDA-approved for weight management, these medications can cause gastrointestinal side effects and should be monitored by a healthcare provider